EssilorLuxottica Societe Anonyme Total Assets 2011-2019 | ESLOY
EssilorLuxottica Societe Anonyme total assets from 2011 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
- EssilorLuxottica Societe Anonyme total assets for the quarter ending December 31, 2019 were $58.893B, a 316.36% increase year-over-year.
- EssilorLuxottica Societe Anonyme total assets for 2019 were $58.893B, a 7.78% increase from 2018.
- EssilorLuxottica Societe Anonyme total assets for 2018 were $54.644B, a 293.04% increase from 2017.
- EssilorLuxottica Societe Anonyme total assets for 2017 were $13.903B, a 4.56% decline from 2016.
| EssilorLuxottica Societe Anonyme Annual Total Assets (Millions of US $) |
|
|---|---|
| 2019 | $58,893 |
| 2018 | $54,644 |
| 2017 | $13,903 |
| 2016 | $14,566 |
| 2015 | $13,293 |
| 2014 | $14,342 |
| 2013 | $10,065 |
| 2012 | $8,883 |
| 2011 | $8,577 |
| 2010 | $6,923 |
| EssilorLuxottica Societe Anonyme Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2019-12-31 | $58,893 |
| 2018-12-31 | $54,644 |
| 2018-06-30 | $15,023 |
| 2017-12-31 | $13,903 |
| 2017-06-30 | $14,145 |
| 2016-12-31 | $14,566 |
| 2015-12-31 | $13,293 |
| 2015-06-30 | $12,875 |
| 2014-12-31 | $14,342 |
| 2014-06-30 | $14,043 |
| 2013-12-31 | $10,065 |
| 2013-06-30 | $9,315 |
| 2012-12-31 | $8,883 |
| 2012-06-30 | $8,685 |
| 2011-12-31 | $8,577 |
| 2011-06-30 | $7,569 |
| 2010-12-31 | $6,923 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $28.492B | $19.479B |
| EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.761B | 33.20 |
| Medtronic (MDT) | Ireland | $129.154B | 20.98 |
| Stryker (SYK) | United States | $70.955B | 27.51 |
| Boston Scientific (BSX) | United States | $51.986B | 30.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.178B | 0.00 |
| Baxter (BAX) | United States | $41.045B | 25.10 |
| Terumo (TRUMY) | Japan | $29.530B | 37.75 |
| ResMed (RMD) | United States | $29.334B | 46.29 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.965B | 22.45 |
| Sunny Optical Technology (SNPTF) | China | $20.566B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.585B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.620B | 70.72 |
| Insulet (PODD) | United States | $13.019B | 1289.81 |
| Quidel (QDEL) | United States | $12.525B | 66.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.849B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| Perrigo (PRGO) | Ireland | $7.514B | 13.44 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.165B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.311B | 15.66 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.203B | 0.00 |
| Neogen (NEOG) | United States | $4.135B | 69.10 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.995B | 0.00 |
| Haemonetics (HAE) | United States | $3.842B | 25.80 |
| ICU Medical (ICUI) | United States | $3.834B | 27.97 |
| Envista Holdings (NVST) | United States | $3.641B | 24.83 |
| Abcam (ABCZY) | $3.406B | 0.00 | |
| Agios Pharmaceuticals (AGIO) | United States | $3.048B | 0.00 |
| NuVasive (NUVA) | United States | $2.754B | 38.38 |
| National Vision Holdings (EYE) | United States | $2.703B | 46.76 |
| TG Therapeutics (TGTX) | United States | $2.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.706B | 157.08 |
| MacroGenics (MGNX) | United States | $1.438B | 0.00 |
| Aphria (APHA) | Canada | $1.408B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.239B | 0.00 |
| Cerus (CERS) | United States | $1.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.197B | 241.13 |
| Vapotherm (VAPO) | United States | $1.124B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.091B | 41.06 |
| Cardiovascular Systems (CSII) | United States | $1.086B | 0.00 |
| PetIQ (PETQ) | United States | $1.062B | 30.68 |
| InMode (INMD) | Israel | $1.053B | 22.24 |
| Owens & Minor (OMI) | United States | $1.047B | 23.74 |
| Phibro Animal Health (PAHC) | United States | $0.951B | 18.96 |
| Quanterix (QTRX) | United States | $0.934B | 0.00 |
| Omeros (OMER) | United States | $0.714B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.670B | 190.82 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.659B | 47.18 |
| Surmodics (SRDX) | United States | $0.640B | 77.15 |
| VAREX IMAGING (VREX) | United States | $0.636B | 15.80 |
| Zynex (ZYXI) | United States | $0.626B | 54.70 |
| LeMaitre Vascular (LMAT) | United States | $0.595B | 36.42 |
| Lantheus Holdings (LNTH) | United States | $0.503B | 11.72 |
| Viemed Healthcare (VMD) | United States | $0.434B | 38.48 |
| Cytosorbents (CTSO) | United States | $0.341B | 0.00 |
| HEXO (HEXO) | $0.338B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.331B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.295B | 25.33 |
| InfuSystems Holdings (INFU) | United States | $0.256B | 141.56 |
| Organigram Holdings (OGI) | Canada | $0.228B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.177B | 0.00 |
| Bovie Medical (APYX) | United States | $0.168B | 0.00 |
| Fonar (FONR) | United States | $0.161B | 14.24 |
| Surface Oncology (SURF) | United States | $0.159B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.149B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.128B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.126B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.124B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.115B | 0.00 |
| Evolus (EOLS) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.089B | 0.00 |
| Nephros (NEPH) | United States | $0.076B | 0.00 |
| United-Guardian (UG) | United States | $0.072B | 16.78 |
| Brainsway (BWAY) | Israel | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.031B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.028B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
